108 related articles for article (PubMed ID: 17928366)
61. A Mek1-Mek2 heterodimer determines the strength and duration of the Erk signal.
Catalanotti F; Reyes G; Jesenberger V; Galabova-Kovacs G; de Matos Simoes R; Carugo O; Baccarini M
Nat Struct Mol Biol; 2009 Mar; 16(3):294-303. PubMed ID: 19219045
[TBL] [Abstract][Full Text] [Related]
62. Navigating the ERK1/2 MAPK Cascade.
Martin-Vega A; Cobb MH
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892237
[TBL] [Abstract][Full Text] [Related]
63. Identification and Characterization of a Novel Dual Inhibitor of Indoleamine 2,3-dioxygenase 1 and Tryptophan 2,3-dioxygenase.
Yoshioka S; Ikeda T; Fukuchi S; Kawai Y; Ohta K; Murakami H; Ogo N; Muraoka D; Takikawa O; Asai A
Int J Tryptophan Res; 2022; 15():11786469221138456. PubMed ID: 36467776
[TBL] [Abstract][Full Text] [Related]
64. MEK2 Negatively Regulates Lipopolysaccharide-Mediated IL-1β Production through HIF-1α Expression.
Talwar H; Bouhamdan M; Bauerfeld C; Talreja J; Aoidi R; Houde N; Charron J; Samavati L
J Immunol; 2019 Mar; 202(6):1815-1825. PubMed ID: 30710049
[TBL] [Abstract][Full Text] [Related]
65.
Gunawardhana N; Jang S; Choi YH; Hong YA; Jeon YE; Kim A; Su H; Kim JH; Yoo YJ; Merrell DS; Kim J; Cha JH
Front Cell Infect Microbiol; 2017; 7():541. PubMed ID: 29379775
[No Abstract] [Full Text] [Related]
66. Role of MEK1 in TLR4 Mediated Signaling.
Bauerfeld C; Samavati L
J Cell Signal; 2017 Mar; 2(1):. PubMed ID: 28804793
[No Abstract] [Full Text] [Related]
67. BPGAP1 spatially integrates JNK/ERK signaling crosstalk in oncogenesis.
Jiang T; Pan CQ; Low BC
Oncogene; 2017 Jun; 36(22):3178-3192. PubMed ID: 28092672
[TBL] [Abstract][Full Text] [Related]
68. Mitogen-Activated Protein Kinase Kinase 2, a Novel E2-Interacting Protein, Promotes the Growth of Classical Swine Fever Virus via Attenuation of the JAK-STAT Signaling Pathway.
Wang J; Chen S; Liao Y; Zhang E; Feng S; Yu S; Li LF; He WR; Li Y; Luo Y; Sun Y; Zhou M; Wang X; Munir M; Li S; Qiu HJ
J Virol; 2016 Nov; 90(22):10271-10283. PubMed ID: 27605672
[TBL] [Abstract][Full Text] [Related]
69. On-Demand Targeting: Investigating Biology with Proximity-Directed Chemistry.
Long MJ; Poganik JR; Aye Y
J Am Chem Soc; 2016 Mar; 138(11):3610-22. PubMed ID: 26907082
[TBL] [Abstract][Full Text] [Related]
70. Biphasic activation of extracellular signal-regulated kinase (ERK) 1/2 in epidermal growth factor (EGF)-stimulated SW480 colorectal cancer cells.
Joo D; Woo JS; Cho KH; Han SH; Min TS; Yang DC; Yun CH
BMB Rep; 2016 Apr; 49(4):220-5. PubMed ID: 26879318
[TBL] [Abstract][Full Text] [Related]
71. MEK1 dependent and independent ERK activation regulates IL-10 and IL-12 production in bone marrow derived macrophages.
Bouhamdan M; Bauerfeld C; Talreja J; Beuret L; Charron J; Samavati L
Cell Signal; 2015 Oct; 27(10):2068-76. PubMed ID: 26208884
[TBL] [Abstract][Full Text] [Related]
72. MEK2 is a prognostic marker and potential chemo-sensitizing target for glioma patients undergoing temozolomide treatment.
He H; Yao M; Zhang W; Tao B; Liu F; Li S; Dong Y; Zhang C; Meng Y; Li Y; Hu G; Luo C; Zong H; Lu Y
Cell Mol Immunol; 2016 Sep; 13(5):658-68. PubMed ID: 26189368
[TBL] [Abstract][Full Text] [Related]
73. ERK2-regulated TIMP1 induces hyperproliferation of K-Ras(G12D)-transformed pancreatic ductal cells.
Botta GP; Reichert M; Reginato MJ; Heeg S; Rustgi AK; Lelkes PI
Neoplasia; 2013 Apr; 15(4):359-72. PubMed ID: 23555182
[TBL] [Abstract][Full Text] [Related]
74. Neurotrophic and neuroprotective actions of (-)- and (+)-phenserine, candidate drugs for Alzheimer's disease.
Lilja AM; Luo Y; Yu QS; Röjdner J; Li Y; Marini AM; Marutle A; Nordberg A; Greig NH
PLoS One; 2013; 8(1):e54887. PubMed ID: 23382994
[TBL] [Abstract][Full Text] [Related]
75. Nuclear translocation of MEK1 triggers a complex T cell response through the corepressor silencing mediator of retinoid and thyroid hormone receptor.
Guo L; Chen C; Liang Q; Karim MZ; Gorska MM; Alam R
J Immunol; 2013 Jan; 190(1):159-67. PubMed ID: 23225884
[TBL] [Abstract][Full Text] [Related]
76. The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control.
Guégan JP; Frémin C; Baffet G
Int J Hepatol; 2012; 2012():328372. PubMed ID: 23133759
[TBL] [Abstract][Full Text] [Related]
77. c-Myc expression and MEK1-induced Erk2 nuclear localization are required for TGF-beta induced epithelial-mesenchymal transition and invasion in prostate cancer.
Amatangelo MD; Goodyear S; Varma D; Stearns ME
Carcinogenesis; 2012 Oct; 33(10):1965-75. PubMed ID: 22791812
[TBL] [Abstract][Full Text] [Related]
78. Monomeric and dimeric models of ERK2 in conjunction with studies on cellular localization, nuclear translocation, and in vitro analysis.
Lee S; Bae YS
Mol Cells; 2012 Apr; 33(4):325-34. PubMed ID: 22450690
[TBL] [Abstract][Full Text] [Related]
79. ERK2 is essential for the growth of human epithelioid malignant mesotheliomas.
Shukla A; Hillegass JM; MacPherson MB; Beuschel SL; Vacek PM; Butnor KJ; Pass HI; Carbone M; Testa JR; Heintz NH; Mossman BT
Int J Cancer; 2011 Sep; 129(5):1075-86. PubMed ID: 21710492
[TBL] [Abstract][Full Text] [Related]
80. An extracellular signal-regulated kinase 2 survival pathway mediates resistance of human mesothelioma cells to asbestos-induced injury.
Shukla A; Barrett TF; MacPherson MB; Hillegass JM; Fukagawa NK; Swain WA; O'Byrne KJ; Testa JR; Pass HI; Faux SP; Mossman BT
Am J Respir Cell Mol Biol; 2011 Nov; 45(5):906-14. PubMed ID: 21454801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
